Kathy Giusti

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Kathy Giusti in 2021

Kathy Giusti (born 1958) is an American business leader who is recognized as a healthcare disrupter.[1] She is a cancer patient and is the Founder and Chief Mission Officer of the Multiple Myeloma Research Foundation (the MMRF).[2] She co-chairs the Harvard Business School (HBS) Kraft Precision Medicine Accelerator,[3] which she helped found, as a Senior Fellow at Harvard Business School.[4]

Kathy is recognized as a pioneer in precision medicine,[4] having seen its vast potential in oncology and other diseases. She uses her patient experience and business acumen to drive science faster with innovative business models across registries, big data, clinical trials, and venture. Kathy is a champion of patient engagement, encouraging each patient take initiative to optimize their own care.[5]

Kathy has been named one of Time magazine's 100 Most Influential People in the world.[6] and ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders.[7]

Kathy Giusti File:GiustiKG.jpg
Born 1958
Alma mater University of Vermont

Harvard Business School

Occupation Chief Mission Officer, the MMRF

Co-chair, Harvard Business School Kraft Precision Medicine Accelerator

Spouse Paul Giusti (m 1990)
Children 2 – Nicole Kathryn (1994); David Paul (1997)


In 1996, Kathy Giusti was diagnosed with multiple myeloma, an incurable blood cancer. When diagnosed, Giusti was 37 years old and was given three years to live. At the time of her diagnosis, there were no new treatments in the pipeline for multiple myeloma.[8]


Early career[edit]

Kathy held executive positions with increasing responsibility in consumer marketing with Gillette/Procter & Gamble and in the pharmaceutical sector of the healthcare industry with Merck & Co. and G.D. Searle & Company (now Pfizer), where she was Executive Director of the Worldwide Arthritis Franchise.[9]

The Multiple Myeloma Research Foundation[edit]

In 1998, with her identical twin sister Karen Andrews, Kathy Founded the Multiple Myeloma Research Foundation (the MMRF). The MMRF’s mission is to accelerate a cure for each and every multiple myeloma patient.

As Founder, CEO, and Chief Mission Officer Kathy has led the MMRF in establishing partnerships and collaborative research models in precision medicine including the Multiple Myeloma Research Consortium (MMRC), the MMRF CoMMpass™ study,[10] CureCloud, the Right Track, and the Myeloma Investment Fund.[11][12][13]

Under Giusti the MMRF has raised more than $500 million to fund research, 15 drugs have been approved to treat multiple myeloma, and many clinical trials are underway.[14] These efforts have accelerated the pace at which treatments are brought to patients and more than tripled patients' survival.[1]

Harvard Business School (HBS)[edit]

Giusti joined the Harvard Business School faculty as Senior Fellow, Co-Chairing the HBS Kraft Precision Medicine Accelerator, a $20 million endowed program provided by Robert Kraft and the Kraft Family Foundation.[3]

The Kraft Accelerator has convened more than 300 leaders from throughout the healthcare and precision medicine ecosystem, from different disease states, and from the investment community. The Kraft Accelerator has identified and published best practices for accelerating cures and created The Kraft Precision Medicine Accelerator Playbook for Cures.[15]

Giusti has co-led the formation of the Kraft Accelerator Leadership Forum, a group of CEOs from disease-focused foundations working together to address the most important challenges, share best practices, and accelerate precision medicine models.  


Kathy has been appointed to multiple positions and advisory boards, all with a focus on developing cures for cancer. These include:

  • National Cancer Advisory Board (NCAB). Appointed by President George W. Bush. Served for six years during the Bush and Obama administrations.[10]
  • Precision Medicine Initiative (PMI) Working Group, appointed by President Obama[16]
  • Biden Cancer Initiative Advisory Committee and Biden Moonshot
  • National Institutes of Health All of US Research Program[16]
  • Faster Cures Advisory Board Changemakers[17]
  • Verily Advisory Board[18]
  • IMS Board[19]
  • EQRx Board[20]


Giusti has received numerous awards for her leadership:  

  • Named one of Time magazine's 100 Most Influential People in the world
  • Ranked #19 on Fortune's list of Worlds' 50 Greatest Leaders
  • Recognized as 1 of 34 leaders changing healthcare by Fortune magazine[21]
  • Named an Open Science Champion of Change by the White House[22]
  • Presented the Harvard Business School Alumni Achievement Award[23]
  • Received the Leadership in Personalized Medicine Award by the Personalized Medicine Coalition.[24]
  • Presented the 2021 American Association for Cancer Research Distinguished Public Service Award[25]
  • Named the Healthcare Businesswomen's Association's Woman of the Year Award[26]

In the Press[edit]

Kathy has been featured in multiple business, healthcare, and mainstream publications:


Kathy has been invited to participate in multiple business, healthcare, and patient-focused podcasts:


Kathy has authored or co-authored multiple articles in business, consumer, and scientific publications:


  1. ^ a b c "These 3 Former Business Leaders Are Disrupting Medicine". Fortune. Retrieved 2021-02-19.
  2. ^ "About the Multiple Myeloma Research Foundation | The MMRF". themmrf.org. Retrieved 2021-02-19.
  3. ^ a b "Kraft Accelerator - Harvard Business School". www.hbs.edu. Retrieved 2021-02-19.
  4. ^ a b "Story Details - Alumni - Harvard Business School". www.alumni.hbs.edu. Retrieved 2021-02-19.
  5. ^ "Harvard Business Publishing Education". hbsp.harvard.edu. Retrieved 2021-02-19.
  6. ^ Couric, Katie (2011-04-21). "The 2011 TIME 100 - TIME". Time. ISSN 0040-781X. Retrieved 2021-02-19.
  7. ^ "UVM Alumna Kathy Giusti Named One of Fortune Magazine's 'World's 50 Greatest Leaders'". www.uvm.edu. Retrieved 2021-02-19.
  8. ^ a b Kincaid, Ellie. "She Was Given Three Years To Live. So She Transformed Cancer Research". Forbes. Retrieved 2021-02-19.
  9. ^ Giusti, Kathy (Feb 17, 2021). "Kathy Giusti LinkedIn". LinkedIn.{{cite web}}: CS1 maint: url-status (link)
  10. ^ a b "Story Details - Alumni - Harvard Business School". www.alumni.hbs.edu. Retrieved 2021-02-19.
  11. ^ MMRF (2020-07-14). "MMRF Launches CureCloud to Democratize Healthcare for Cancer Patients". themmrf.org. Retrieved 2021-02-19.
  12. ^ a b "4 Important Steps to Take After a Cancer Diagnosis". Time. Retrieved 2021-02-19.
  13. ^ MMRF (2019-04-23). "Multiple Myeloma Research Foundation (MMRF) Launches Innovative Fund to Accelerate New Myeloma Treatments". themmrf.org. Retrieved 2021-02-19.
  14. ^ MMRF (2020-12-04). "The MMRF Drives Unparalleled Advances for Multiple Myeloma Patients". themmrf.org. Retrieved 2021-02-19.
  15. ^ "Kraft Accelerator - Harvard Business School". www.hbs.edu. Retrieved 2021-02-19.
  16. ^ a b "Kathy Giusti, M.B.A." National Institutes of Health (NIH) — All of Us. 2020-08-27. Retrieved 2021-02-19.
  17. ^ "FasterCures Changemakers: Disruptive Philanthropy for Patients". milkeninstitute.org. Retrieved 2021-02-19.
  18. ^ "Leadership | Verily Life Sciences". verily.com. Retrieved 2021-02-19.
  19. ^ "Multiple Myeloma Research Foundation (MMRF) Founder, CEO Receives American Society of Clinical Oncology's Partners In Progress Award". BioSpace. Retrieved 2021-02-19.
  20. ^ "EQRx Appoints Kathy Giusti to Board of Directors". EQRx. 2021-09-27. Retrieved 2021-09-27.
  21. ^ "34 Leaders Who Are Changing Health Care". Fortune. Retrieved 2021-02-19.
  22. ^ "Democratizing the Science, Accelerating the Cure". whitehouse.gov. 2013-06-20. Retrieved 2021-02-19.
  23. ^ "Story Details - Alumni - Harvard Business School". www.alumni.hbs.edu. Retrieved 2021-02-19.
  24. ^ "Personalized Medicine Coalition - Advocates for precision medicine : PMC Press Releases : Press Releases : Personalized Medicine Coalition Recognizes Kathy Giusti with Award for Leadership". www.personalizedmedicinecoalition.org. Retrieved 2021-02-19.
  25. ^ "Giusti, Pelosi, and Sawyers to Receive American Association for Cancer Research Distinguished Public Service Awards | AACR | News Releases". American Association for Cancer Research (AACR). Retrieved 2021-04-21.
  26. ^ "Woman of the Year Past Recipients | HBA". www.hbanet.org. Retrieved 2021-02-19.
  27. ^ Giusti, Kathy. "Reducing Racial Disparities in Cancer Treatment Demands Collective Action". Harvard Business Review. Retrieved 2022-06-13.
  28. ^ Giusti, Kathy. "HI've Been Diagnosed With Two Different Cancers—This Is What I've Learned". Prevention. Retrieved 2022-06-17.
  29. ^ Giusti, Kathy. "How to reduce racial disparities in cancer". The Hill. Retrieved 2022-04-13.
  30. ^ Giusti, Kathy. "How One Woman Used Her Multiple Myeloma Diagnosis to Fuel the Search for a Cure". Health. Retrieved 2021-10-19.
  31. ^ Giusti, Kathy. "acial gaps persist in cancer care — here's how we can close them". The Hill. Retrieved 2021-10-19.
  32. ^ Giusti, Kathy. "Reducing Racial Disparities in Cancer Outcomes". Harvard Business Review. Retrieved 2021-10-19.
  33. ^ Giusti, Opinion by Kathy. "Opinion: Colin Powell showed that even the bravest are vulnerable". CNN. Retrieved 2021-10-19.
  34. ^ Todd, Deborah (2021-10-05). "50 years later, women still lead the charge in the fight against cancer". TheHill. Retrieved 2021-10-07.
  35. ^ Georgiadis, Candice (2021-09-20). "Female Disruptors: Kathy Giusti Of The Multiple Myeloma Research Foundation (MMRF) On The Three…". Authority Magazine. Retrieved 2021-10-07.
  36. ^ Giusti, Kathy (2021-06-30). "Kathy Giusti: Warp Speed to cancer cures – COVID vaccine should be our model to save more lives". Fox News. Retrieved 2021-08-10.
  37. ^ Events, Reuters. "Reuters Events: Digital Health". Reuters Events: Digital Health. Retrieved 2021-07-23.
  38. ^ Giusti, Opinion by Kathy. "Opinion: What Covid can teach us about cancer". CNN. Retrieved 2021-04-21.
  39. ^ Wolfe, Alexandra (2018-05-25). "An Urgent Mission to Speed Progress Against Cancer". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-02-19.
  40. ^ Marcus, Amy Dockser (2015-09-28). "How One Family Faced Difficult Decisions About DNA Sequencing". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-02-19.
  41. ^ Bryant, Adam (2016-10-07). "Kathy Giusti: Sharing Life Lessons From a Death Sentence (Published 2016)". The New York Times. ISSN 0362-4331. Retrieved 2021-02-19.
  42. ^ Quintanilla, Carl. "The Money Chase: Harvard Business School". www.cnbc.com. Retrieved 2021-02-19.
  43. ^ M+A (2020-05-22). "Managing Through Crisis: Why Urgency Can Bring Clarity". Kathy Giusti. Retrieved 2021-02-19.
  44. ^ M+A (2020-04-29). "Kathy Giusti on Everyone Talks to Liz Claman". Kathy Giusti. Retrieved 2021-02-19.
  45. ^ M+A (2020-03-09). "Kathy Giusti on Better Together with Maria Menounos". Kathy Giusti. Retrieved 2021-02-19.
  46. ^ "Kathy Giusti". PharmaVOICE. Retrieved 2021-02-19.
  47. ^ "#44: Kathy Giusti, Cancer Fighter and Health Care Revolutionary - No Limits with Rebecca Jarvis". iHeartRadio. Retrieved 2021-02-19.
  48. ^ "Addressing Demographic Disparities in Clinical Trials". Harvard Business Review. 2021-06-11. ISSN 0017-8012. Retrieved 2021-06-21.
  49. ^ "A New Playbook for Cure-Seeking Nonprofits". The Journal of Precision Medicine. Retrieved 2021-02-19.
  50. ^ "How Nonprofit Foundations Can Sustainably Fund Disease Research". Harvard Business Review. 2020-09-30. ISSN 0017-8012. Retrieved 2021-02-19.
  51. ^ "What It Takes to Lead a Disease Research Foundation". Harvard Business Review. 2020-08-18. ISSN 0017-8012. Retrieved 2021-02-19.
  52. ^ "How Medical Nonprofits Set Winning Strategy". Harvard Business Review. 2020-03-06. ISSN 0017-8012. Retrieved 2021-02-19.
  53. ^ "One Obstacle to Curing Cancer: Patient Data Isn't Shared". Harvard Business Review. 2016-11-28. ISSN 0017-8012. Retrieved 2021-02-19.
  54. ^ "What Cancer Researchers Can Learn from Direct-to-Consumer Companies". Harvard Business Review. 2017-01-12. ISSN 0017-8012. Retrieved 2021-02-19.
  55. ^ Giusti, Kathy; Young, Anne Quinn; Lehrhaupt, Kerri (May–June 2018). "Closing Knowledge Gaps to Optimize Patient Outcomes and Advance Precision Medicine". Cancer Journal (Sudbury, Mass.). 24 (3): 144–151. doi:10.1097/PPO.0000000000000319. ISSN 1540-336X. PMID 29794540.
  56. ^ Giusti, Kathy; Young, Anne Quinn; Winget, Melissa; Lehrhaupt, and Kerri (2017-04-11). "Understanding Differences in Critical Decisions in the Multiple Myeloma Patient Journey in the Era of Precision Medicine". American Journal of Hematology/Oncology. 13 (3).

External links[edit]